Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06929065 · ClinicalTrials.gov registry record · NA
Randomized Trial of HIFU vs. Cryo for Prostate Cancer
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06929065 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 50 participants.
The verdict
NCT06929065, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
HIFU has been FDA approved and is widely utilized across the United States and Europe for the treatment of prostate cancer. Despite this, HIFU has not been offered within SCPMG until now due to growing patient demand. We have offered cryoablation. This pilot study will determine the efficacy of HIFU vs. cryoablation focal therapy for early stage prostate cancer within SCPMG. We hope to elucidate whether outcomes are similar between the two modalities.
Interventions
- PROCEDURE HIFU vs Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06929065
The ClinicalTrials.gov registry entry for NCT06929065 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HIFU vs Cryoablation is the first listed.
NCT06929065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06929065 about?
NCT06929065 is a clinical study titled "Randomized Trial of HIFU vs. Cryo for Prostate Cancer". HIFU has been FDA approved and is widely utilized across the United States and Europe for the treatment of prostate cancer. Despite this, HIFU has not been offered within SCPMG until now due to growing patient demand. We have offered cryoablation. This pilot study will determine the efficacy of HIFU...
What is the current status of trial NCT06929065?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-04-01. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT06929065?
The interventions under investigation include: HIFU vs Cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT06929065?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.